Cargando…
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy
BACKGROUND: Randomized controlled trials (RCTs) have been conducted, stratifying idiopathic immunoglobulin A nephropathy (IgAN) patients based on the laboratory findings [serum creatinine, estimated glomerular filtration rate (eGFR) and daily proteinuria]. In contrast, data from kidney biopsy have b...
Autores principales: | Schena, Francesco P, Tripepi, Giovanni, Rossini, Michele, Abbrescia, Daniela I, Manno, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050523/ https://www.ncbi.nlm.nih.gov/pubmed/35498888 http://dx.doi.org/10.1093/ckj/sfab263 |
Ejemplares similares
-
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy
por: Schena, Francesco P, et al.
Publicado: (2022) -
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy: Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients
por: Schena, Francesco Paolo, et al.
Publicado: (2021) -
Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review
por: Schena, Francesco Paolo, et al.
Publicado: (2023) -
Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020) -
Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
por: Scarpati, Giuliana, et al.
Publicado: (2021)